Cite
HARVARD Citation
Dimou, M. et al. (2021). Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas. Hematological oncology. 39 (3), pp. 336-348. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dimou, M. et al. (2021). Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas. Hematological oncology. 39 (3), pp. 336-348. [Online].